| Name |
Relpax 40 mg filmom obložene tablete |
| Marketing Authorisation Number |
HR-H-319261647 |
| Active Substance |
eletriptanbromid |
| Composition |
jedna filmom obložena tableta sadrži 40 mg eletriptana (u obliku eletriptanbromida) |
| Pharmaceutical Form |
filmom obložena tableta |
| Manufacturer |
Pfizer Italia S.r.l., Ascoli Piceno, Italija |
| Marketing Authorisation Holder |
Viatris Hrvatska d.o.o., Koranska 2, Zagreb, Hrvatska |
| Marketing Authorisation Date |
23.02.2026 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/17-02/609 |
| Registration Number |
381-12-01/70-26-25 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product on medical prescription for non-renewable delivery
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
N02CC06 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
